Fidelity Select Pharmaceuticals Portfolio (FPHAX)
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments.
Fund Info
US3163904424
316390442
Jun 17, 2001
$0
Large-Cap
Growth
Expense Ratio
FPHAX features an expense ratio of 0.75%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Fidelity Select Pharmaceuticals Portfolio, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Fidelity Select Pharmaceuticals Portfolio had a return of 10.68% year-to-date (YTD) and 13.32% in the last 12 months. Over the past 10 years, Fidelity Select Pharmaceuticals Portfolio had an annualized return of 3.44%, while the S&P 500 had an annualized return of 11.11%, indicating that Fidelity Select Pharmaceuticals Portfolio did not perform as well as the benchmark.
FPHAX
10.68%
-2.21%
-13.10%
13.32%
3.16%
3.44%
^GSPC (Benchmark)
25.25%
0.08%
9.66%
25.65%
13.17%
11.11%
Monthly Returns
The table below presents the monthly returns of FPHAX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 5.17% | 8.54% | 3.82% | -2.71% | 5.48% | 3.38% | -0.40% | 7.01% | -6.17% | -5.10% | -2.17% | 10.68% | |
| 2023 | 0.04% | -4.48% | 4.32% | 0.70% | 0.22% | 1.96% | -0.39% | 3.14% | -4.50% | -4.10% | 4.46% | 3.44% | 4.30% |
| 2022 | -5.44% | 0.45% | 5.15% | -3.46% | -0.92% | 1.24% | 2.32% | -5.85% | -2.45% | 6.42% | 5.50% | -4.68% | -2.74% |
| 2021 | 1.35% | -0.33% | -0.29% | -0.82% | 3.22% | 3.86% | 0.51% | 2.36% | -5.11% | 4.29% | -6.25% | -0.90% | 1.29% |
| 2020 | -0.60% | -6.30% | -3.36% | 9.15% | 3.02% | 0.68% | 1.56% | 1.87% | -0.65% | -6.17% | 7.93% | -2.99% | 2.91% |
| 2019 | 3.58% | 5.61% | 1.47% | -5.91% | -3.09% | 8.75% | -1.42% | 0.72% | 0.43% | 5.41% | 3.87% | 2.02% | 22.61% |
| 2018 | 5.50% | -3.88% | 1.22% | -1.83% | 1.66% | 0.69% | 7.55% | 4.05% | 1.03% | -5.93% | 4.63% | -8.32% | 5.21% |
| 2017 | -0.76% | 7.10% | 0.50% | 1.12% | 1.80% | 2.14% | -0.52% | 0.37% | 1.00% | -3.74% | 0.92% | 0.35% | 10.38% |
| 2016 | -7.10% | -4.76% | -0.11% | 2.92% | 2.08% | -0.58% | 5.79% | -4.68% | -1.15% | -8.40% | -1.38% | 0.72% | -16.27% |
| 2015 | 1.92% | 5.92% | 2.56% | 1.02% | 4.59% | -1.29% | 5.46% | -8.47% | -8.20% | 4.06% | 0.73% | -5.71% | 1.12% |
| 2014 | 1.67% | 9.52% | -2.67% | 2.38% | 0.65% | 4.12% | -2.77% | 3.97% | 2.45% | 1.98% | 3.61% | -6.46% | 19.05% |
| 2013 | 6.58% | 0.62% | 5.08% | 4.52% | 0.92% | -1.09% | 5.60% | -1.69% | 3.50% | 3.76% | 6.06% | 3.48% | 43.87% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of FPHAX is 49, indicating average performance compared to other mutual funds on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Fidelity Select Pharmaceuticals Portfolio provided a 0.20% dividend yield over the last twelve months, with an annual payout of $0.05 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.05 | $0.15 | $0.30 | $0.28 | $0.31 | $0.31 | $0.28 | $0.25 | $0.18 | $1.15 | $1.24 | $2.14 |
Dividend yield | 0.20% | 0.63% | 1.33% | 1.17% | 1.31% | 1.31% | 1.44% | 1.33% | 1.07% | 5.59% | 5.81% | 11.12% |
Monthly Dividends
The table displays the monthly dividend distributions for Fidelity Select Pharmaceuticals Portfolio. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.15 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.25 | $0.30 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.28 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.24 | $0.31 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.31 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.28 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.25 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.18 | $0.18 |
| 2015 | $0.00 | $0.00 | $0.00 | $1.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $1.15 |
| 2014 | $0.00 | $0.00 | $0.00 | $1.15 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.09 | $1.24 |
| 2013 | $0.35 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.79 | $2.14 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Select Pharmaceuticals Portfolio. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Select Pharmaceuticals Portfolio was 37.34%, occurring on Jul 23, 2002. Recovery took 868 trading sessions.
The current Fidelity Select Pharmaceuticals Portfolio drawdown is 17.42%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -37.34% | Oct 23, 2001 | 187 | Jul 23, 2002 | 868 | Jan 3, 2006 | 1055 |
| -32.91% | Aug 6, 2015 | 316 | Nov 3, 2016 | 781 | Dec 12, 2019 | 1097 |
| -30.35% | Aug 18, 2008 | 135 | Mar 2, 2009 | 181 | Nov 16, 2009 | 316 |
| -25.4% | Dec 20, 2019 | 63 | Mar 23, 2020 | 72 | Jul 6, 2020 | 135 |
| -20.95% | Nov 5, 2021 | 223 | Sep 26, 2022 | 343 | Feb 7, 2024 | 566 |
Volatility
Volatility Chart
The current Fidelity Select Pharmaceuticals Portfolio volatility is 5.31%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.